Open AccessReal-World Evidence Prediction of a Phase IV Oncology Trial: Comparative Degarelix vs Leuprolide Safety
Author(s) -
David Merola,
Sebastian Schneeweiß,
Sushama Kattinakere Sreedhara,
Luke E. Zabotka,
Kenneth Quinto,
John Concato,
Shirley Wang
Publication year - 2022
Publication title -
jnci cancer spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.345
H-Index - 10
ISSN - 2515-5091
DOI - 10.1093/jncics/pkac049
Subject(s) - medicine , propensity score matching , hazard ratio , prostate cancer , confidence interval , observational study , androgen deprivation therapy , adverse effect , oncology , cancer , intensive care medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom